sastium 100 mg tabletki powlekane
accord healthcare polska sp. z o.o. - sertralinum - tabletki powlekane - 100 mg
aposerta 50 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - sertralini hydrochloridum - tabletki powlekane - 50 mg
aposerta 100 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - sertralini hydrochloridum - tabletki powlekane - 100 mg
grasustek
juta pharma gmbh - pegfilgrastim - neutropenia - Иммуностимуляторы, - zmniejszenie czasu trwania neutropenii i występowanie neutropenii z gorączką u dorosłych pacjentów leczonych chemioterapią cytotoksyczną pod kątem złośliwości (z wyjątkiem przewlekłej białaczki szpikowej i zespołów mielodysplastycznych).
osteoteri 20 mcg/80 mcl roztwór do wstrzykiwań we wstrzykiwaczu
g.l. pharma gmbh - teriparatidum - roztwór do wstrzykiwań we wstrzykiwaczu - 20 mcg/80 mcl
ryaltris 600 mcg + 25 mcg/dawkę aerozol do nosa, zawiesina
glenmark pharmaceuticals s.r.o. - olopatadinum + mometasoni furoas - aerozol do nosa, zawiesina - 600 mcg + 25 mcg/dawkę
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
sondelbay
accord healthcare s.l.u. - teryparatyd - osteoporoza - wapń homeostaza - sondelbay is indicated in adults. leczenie osteoporozy u kobiet po menopauzie iu mężczyzn ze zwiększonym ryzykiem złamań. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. leczenie osteoporozy, związanego ze stałą systemowej terapii glukokortykosteroidy, u kobiet i mężczyzn z podwyższonym ryzykiem złamań.
teriparatide sun
sun pharmaceutical industries europe b.v. - teryparatyd - osteoporosis; osteoporosis, postmenopausal - wapń homeostaza - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
kauliv
strides pharma (cyprus) limited - teryparatyd - osteoporosis; osteoporosis, postmenopausal - wapń homeostaza - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.